Previous Close | 0.2100 |
Open | 0.2150 |
Bid | 0.2100 x 0 |
Ask | 0.2350 x 0 |
Day's Range | 0.2100 - 0.2150 |
52 Week Range | 0.2100 - 0.3500 |
Volume | |
Avg. Volume | 8,736 |
Market Cap | 14.812M |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings Date | Mar 19, 2024 - Mar 25, 2024 |
Forward Dividend & Yield | 0.01 (4.76%) |
Ex-Dividend Date | Dec 28, 2023 |
1y Target Est | 4.25 |
TORONTO, ON / ACCESSWIRE / March 12, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the issuance of an aggregate of 390,625 common shares at a price of $0.32 in respect of the second and third quarterly equity payments under ...
TORONTO, ON / ACCESSWIRE / December 29, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") announces the retirement of Dave Bennett from its Board of Directors as he has accepted a senior executive role in the industry and as such will be devoting ...
TORONTO, ON / ACCESSWIRE / December 20, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding common ...